NEW YORK (GenomeWeb News) – Norwegian sample preparation firm NorDiag today said it has completed its merger with wholly owned subsidiary Genpoint.
The merger was announced in May as a way to reduce costs to both companies. As part of the transaction, all Genpoint employees are being offered employment with NorDiag, which acquired Genpoint in 2007.
The transaction was carried out with accounting and taxation effect from January 2010, NorDiag said in a statement.
Based in Oslo, NorDiag develops tools for the sample preparation of DNA from difficult biological samples such as stool, urine, and sputum. Genpoint, also based in Oslo, develops and markets nucleic acid sample preparation products for use in DNA-based diagnostics.